90531-65-0 Usage
Functional groups
Propanediol, aminoethyl, benzoate
The compound contains a propanediol backbone, an aminoethyl group, and a benzoate group, which contribute to its chemical properties and reactivity.
Substituents
Dimethoxyphenyl, aminobenzoate
The presence of dimethoxyphenyl and aminobenzoate substituents on the molecule influence its chemical behavior and potential applications.
Usage as an intermediate
Synthesis of pharmaceuticals and organic compounds
The compound is commonly used as an intermediate in the synthesis of various pharmaceuticals and organic compounds due to its reactive functional groups.
Potential applications
Polymer production, solvent in chemical processes
The compound may have applications in the production of polymers and as a solvent in various chemical processes, taking advantage of its unique structure and reactivity.
Medical and biotechnological applications
Drug formulation, biochemical research tools
With its versatile structure and functional groups, the compound has potential uses in the field of medicine and biotechnology, such as in drug formulation and the development of biochemical research tools.
Check Digit Verification of cas no
The CAS Registry Mumber 90531-65-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,5,3 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 90531-65:
(7*9)+(6*0)+(5*5)+(4*3)+(3*1)+(2*6)+(1*5)=120
120 % 10 = 0
So 90531-65-0 is a valid CAS Registry Number.
90531-65-0Relevant academic research and scientific papers
propanolamines. 1. Novel β-Blockers with Ultrashort Duration of Action
Kam, Sheung-Tsam,Matier, William L.,Mai, Khuong X.,Barcelon-Yang, Cynthia,Borgman, Robert J.,et al.
, p. 1007 - 1016 (2007/10/02)
Novel propanolamines were synthesized and investigated as potential ultrashort-acting β-adrenergic receptor blockers.Many of these analogues exhibited good potency and short duration.The N-ureidoalkyl analogue 85 (ACC-9089) has a potency equal to propranolol and a duration of action of about 21 min in the dog.It has been selected as a candidate for further clinical study.Structure-activity relationships and structure-duration relationships for these new β-blockers are also discussed.
